Cite
HARVARD Citation
Mo, D. et al. (2022). Efficacy of immune checkpoint inhibitor as maintenance therapy for advanced or metastatic cancers: A meta-analysis of randomized controlled trials. Medicine. 101 (38), pp. e30830-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mo, D. et al. (2022). Efficacy of immune checkpoint inhibitor as maintenance therapy for advanced or metastatic cancers: A meta-analysis of randomized controlled trials. Medicine. 101 (38), pp. e30830-. [Online].